Structure and Function of the Phospholipase AィイD22ィエD2 Inhibitor Having Leucine-rich Repeats
富含亮氨酸重复序列的磷脂酶 AD22 抑制剂的结构和功能
基本信息
- 批准号:10672074
- 负责人:
- 金额:$ 2.37万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1. A large-scale purification of phospholipase AィイD22ィエD2 inhibitors from the serum of Chinese mamushi and the crystallization of the inhibitorsWe have purified three types of phospholipase AィイD22ィエD2 inhibitors (PLIα, PLIβ, and PLIγ) by the sequential chromatography on Blue-Sepharose FF, Q-Sepharose FF, Phenyl-Sepharose HP, and Superdex 200pg columns. Finally, 10 mg of the purified PLIα, 5 mg of the PLIβ, and 20 mg of the PLIγ could be obtained from 10 ml of the Chinese mamushi serum. We are determining the best crystallization conditions of these inhibitors by the standard technique of vapor diffusion with the hanging drop methods. By this time, we could not obtain the crystals suitable for X-ray crystallography.2. Establishment of the bacterial expression system for PLAィイD22ィエD2 inhibitors and elucidation of their structure function relationships by means of the site-directed mutagenesis analysisThe PLIα cDNA was subcloned into the expression vector pET-16b and used to transform Esc … More herichia coli. We could obtain the recombinant protein having the inhibition activity as strong as that of the natural PLIα. Alternatively, we have identified a PLIα-like protein (PLIα-LP) from the serum of the non-venomous striated snake and cloned its cDNA. The purified PLIα-LP was found to have no inhibitory activity toward any PLAィイD22sィエD2, although its amino acid sequence showed about 70% homology to that of Chinese mamushi PLIα. We have constructed the recombinant chimeric proteins between the PLIα-LP and Chinese mamushi PLIα and examined their inhibitory activity in order to specify the region responsible for the PLAィイD22ィエD2 inhibition. It was suggested that the CRD structure in the PLIα molecule played the basic structural roles such as the formation of trimeric structure and that the N-terminal and C-terminal regions of PLIα other than CRD were required for the interaction of PLIα to a PLAィイD22ィエD2 molecule.3. Purification of leucine-rich αィイD22ィエD2 glycoprotein (LRG) from the human serum and the examination of its PLAィイD22ィエD2 inhibitory activity.Using the synthesized peptide (LRG1-20) corresponding to the reported N-terminal 20 amino acid sequence of LRG as an antigen, we immunized a rabbit and obtained the anti-LRG1-20 antibody. The ELISA using this antibody was found to be a good tool for detecting LRG during the purification of LRG from human serum. Less
1. 采用Blue-Sepharose FF、Q-Sepharose FF、Phenyl-Sepharose HP和Superdex 200pg色谱柱,对3种磷脂酶(PLIα、PLIβ和PLIγ)抑制剂进行了纯化。最后,从10 ml中国马木鱼血清中可得到纯化的PLIα 10 mg、PLIβ 5 mg和PLIγ 20 mg。我们用悬挂滴法的标准蒸汽扩散技术确定了这些抑制剂的最佳结晶条件。此时,我们还不能得到适合x射线晶体学的晶体。建立细菌表达系统的解放军ィイD22摊位ィエD2抑制剂和说明其结构功能的关系通过定点诱变analysisThe PLIαcDNA subcloned进入表达载体pET-16b和用于转换Esc ... 更多的herichia杆菌。我们可以获得与天然PLIα具有相同抑制活性的重组蛋白。另外,我们从无毒条纹蛇的血清中鉴定出一种pli α-样蛋白(PLIα-LP),并克隆了其cDNA。纯化后的PLIα- lp对PLA γ γ γ γ - 22和γ γ - D2均无抑制活性,但其氨基酸序列与中国马木鱼PLIα同源性约为70%。我们构建了PLIα- lp与中国马马鱼PLIα之间的重组嵌合蛋白,并检测了它们的抑制活性,以确定抑制PLA γ γ γ γ - D22 γ γ - D2的区域。建议PLIαCRD结构分子的基本结构等角色的形成三聚物的结构和PLIα的氨基端和c端区域交互所需的其他比CRD PLIα的解放军ィイD22摊位ィエD2 molecule.3。人血清中富含亮氨酸的α γ γ γ - D22 γ - D2糖蛋白(LRG)的纯化及其对PLA γ - D22 γ - D2抑制活性的检测。利用合成的LRG n端20氨基酸序列对应的肽段(LRG1-20)作为抗原免疫家兔,获得抗LRG1-20抗体。在人血清中LRG的纯化过程中,使用该抗体的ELISA检测是一种较好的工具。少
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Okumura, K., Inoue, S., Ohkura, N., Ikeda, K., and Hayashi, K.: "cDNA Cloning of the Two Subunits of Phospholipase AィイD22ィエD2 Inhibitor PLIγ from Blood Plasma of the Chinese Mamushi, Agkistrodon blomhoffii siniticus"IUBMB Life. 48 (1). 99-104 (1999)
Okumura, K.、Inoue, S.、Ohkura, N.、Ikeda, K. 和 Hayashi, K.:“从中国 Mamushi、Agkistrodon blomhoffii siniticus 血浆中克隆磷脂酶 AiiD22IeD2 抑制剂 PLIγ 的两个亚基的 cDNA” IUBMB 生活。48 (1)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Okumura, K., Inoue, S., Ikeda, K., and Hayashi, K.: "cDNA cloning and Bacterial Expression of Phospholipase AィイD22ィエD2 Inhibitor PLIα from the Serum of the Chinese Mamushi, Agkistrodon blomhoffii siniticus"Biochim. Biophys. Acta.. 1441 (1). 51-60 (1999)
Okumura, K.、Inoue, S.、Ikeda, K. 和 Hayashi, K.:“来自中国 Mamushi、Agkistrodon blomhoffii siniticus 血清的磷脂酶 A-D22-D2 抑制剂 PLIα 的 cDNA 克隆和细菌表达”Biochim。生物物理学报。1441(1)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ohkura, N., Kitahara, Y., Inoue, S., Ikeda, K., and Hayahsi, K.: "Isolation and Amino Acid Sequence of a Phospholipase AィイD22ィエD2 inhibitor from the Blood Plasma of the Sea Krait, Laticauda semifasciata"J. Biochem.. 125 (2). 375-382 (1999)
Ohkura, N.、Kitahara, Y.、Inoue, S.、Ikeda, K. 和 Hayahsi, K.:“从海蛇血浆中分离出磷脂酶 A-D22-D2 抑制剂和氨基酸序列, Laticauda semifasciata”J.Biochem.125(2).375-382(1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Okumura,K.: "cDNA Cloning of the Two Subunits of Phospholipase A_2 Inhibitor PLIγ form Blood Plasma of the Chinese Mamushi, Agkistrodon blomhoffii siniticus"IUBMB Life. 48(1). 99-104 (1999)
Okumura, K.:“中国 Mamushi、Agkistrodon blomhoffii siniticus 血浆中磷脂酶 A_2 抑制剂 PLIγ 的两个亚基的 cDNA 克隆”IUBMB Life 48(1)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Okumura, K.: "Purification, Characterization and cDNA Cloning of a Phospholipase A_2 Inhibitor from the Serum of the Non-venomous snake Elaphe quadrivirgata"Biochem. J.. 341(1). 165-171 (1999)
Okumura, K.:“无毒蛇 Elaphequadrivirgata 血清中磷脂酶 A_2 抑制剂的纯化、表征和 cDNA 克隆”Biochem。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
INOUE Seiji其他文献
INOUE Seiji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('INOUE Seiji', 18)}}的其他基金
Role of cytochrome c as a novel signaling molecule by the investigation of LRG knock-out mouse
通过LRG敲除小鼠研究细胞色素c作为新型信号分子的作用
- 批准号:
23590096 - 财政年份:2011
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Structure and function of three types of phospholipase A_2 inhibitor s derived from the blood of venomous snakes
三种毒蛇血磷脂酶A_2抑制剂的结构与功能
- 批准号:
12672137 - 财政年份:2000
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AN EXPANDING NEW SOCIAL-DEMOCRATIC CONSCIOUSNESS IN EUROPEAN SOCIETY AND EDUCATION : WHAT INFLUENCES ON JAPANESE POLITICS AND EDUCATION?
欧洲社会和教育中不断扩大的新社会民主意识:对日本政治和教育有何影响?
- 批准号:
11410076 - 财政年份:1999
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Inhibition Mechanism of a Novel Phospholipase A_2 Inhibitor from the Blood of the Venomous Snakes
毒蛇血磷脂酶A_2新型抑制剂的抑制机制
- 批准号:
07672400 - 财政年份:1995
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Comparative Study on the Selection and Self-Realization Process of Japanese and French Youth under their Official and Hidden Curricula
日本和法国青少年在官方和隐性课程下的选择和自我实现过程的比较研究
- 批准号:
04301033 - 财政年份:1992
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Co-operative Research (A)
相似国自然基金
丹参酮ⅡA联合miR-29b inhibitor调控TGF-β1 / Smad3协同促进肌腱功能修复的机制研究
- 批准号:81702135
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
石斑鱼凋亡抑制因子Bax inhibitor 1(BI-1)在虹彩病毒SGIV侵染中的功能研究
- 批准号:31402335
- 批准年份:2014
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
马铃薯invertase inhibitor基因克隆及抗低温糖化品质改良
- 批准号:30270842
- 批准年份:2002
- 资助金额:20.0 万元
- 项目类别:面上项目
C1-Inhibitor在真核细胞中表达的研究
- 批准号:39270620
- 批准年份:1992
- 资助金额:4.0 万元
- 项目类别:面上项目
相似海外基金
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
CCA's lineage heterogeneity and subsequent adaptive reprogramming upon acquired resistant to CDK4/6 inhibitor.
CCA 的谱系异质性以及随后获得对 CDK4/6 抑制剂耐药性后的适应性重编程。
- 批准号:
24K18491 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
敗血症におけるplasminogen activator inhibitor-1阻害の効果検証
验证纤溶酶原激活剂抑制剂-1 抑制在脓毒症中的有效性
- 批准号:
24K02544 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
FMO/ML-Guided Drug Design: Accelerating Novel Inhibitor Development and Drug Discovery
FMO/ML 引导的药物设计:加速新型抑制剂的开发和药物发现
- 批准号:
24K20888 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Continuing Grant
大腿骨頭壊死に対するSclerostin inhibitorによる骨再生の検討
使用 Sclerostin 抑制剂检查股骨头坏死骨再生
- 批准号:
24K12348 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a Cathepsin V inhibitor for application as an anti-tumour agent.
开发用作抗肿瘤剂的组织蛋白酶 V 抑制剂。
- 批准号:
MR/Y503447/1 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Research Grant
Indication selection, patient stratification, and IND preparation for STX-002: the first-in-class LRG1 inhibitor for treatment of chronic kidney disease and immunotherapy-resistant tumours.
STX-002的适应症选择、患者分层和IND准备:用于治疗慢性肾病和免疫治疗耐药肿瘤的一流LRG1抑制剂。
- 批准号:
10092585 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Collaborative R&D
Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
胆红素分解代谢诱导纤溶酶原激活剂抑制剂 1 (PAI-1) 恶化代谢功能障碍
- 批准号:
10750132 - 财政年份:2024
- 资助金额:
$ 2.37万 - 项目类别:
Identification of novel therapeutic target and mechanism for PARP inhibitor combination therapy
PARP抑制剂联合治疗的新治疗靶点和机制的鉴定
- 批准号:
23K08100 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)